FDA approval
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
FDA approval
May 18, 2024, 02:46 |
Drugs
Vivek Subbiah: US FDA granted accelerated approval to tarlatamab-dlle
Vivek Subbiah shared on X: "New FDA Approval. Today the US FDA granted accelerated approval…
Apr 29, 2024, 07:58 |
Blog
Rahul Gosain: FDA approval of Fruquintinib from FRESCO2 and how it fits in our Rx paradigm with N. Arvind Dasari
Rahul Gosain, Co-Founder of Oncology Brothers podcast and Director of Regional Infusion Services and Medical…
Apr 26, 2024, 10:07 |
Drugs
Rami Manochakian: U.S. FDA approves adjuvant Alectinib in patients with stage IB-IIIA ALK+Non-Small Cell Lung Cancer
Rami Manochakian, Associate Professor and Thoracic Oncologist at Mayo Clinic, shared on X/Twitter: ''HOT OFF…
Apr 24, 2024, 09:13 |
Drugs
FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer
FDA, the Food and Drug Administration, approved nogapendekin alfa inbakicept-pmln (Anktiva, Altor BioScience, LLC) with…
Mar 28, 2024, 03:11 |
Drugs
Yüksel Ürün: US FDA approves mirvetuximab soravtansine-gynx for FRα+ platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer
Yüksel Ürün, Professor of Medical Oncology at Ankara University School of Medicine, shared a post…
Mar 5, 2024, 19:49 |
Insight
Eric K. Singhi: Great to see this option approved for our patients with Exon 20 Group insertions
Eric K. Singhi, Thoracic Medical Oncologist and Assistant Professor at the MD Anderson Cancer Center,…
Feb 25, 2024, 15:31 |
Opinion
Aaron Goodman: Until a trial demonstrates melflufen is superior to melphalan I see no reason to use it
Aaron Goodman shared a post on X: "Chemo is bad and toxic! Attach a peptide…
Jan 22, 2024, 14:19 |
Blog
Vivek Subbiah: 'Was great to partner with her and the team on the Selpercatinib RET fusion tissue agnostic approval
Vivek Subbiah recently shared on X/Twitter: "So nice to catch up with the terrific Dr.…
Dec 30, 2023, 04:09 |
Drugs
Spencer Knight: Here’s the current 34 approval breakdown by therapeutic area
Spencer Knight, Senior Business Consultant of Cell and Gene Therapy at Charlton Morris, shared on…
Dec 27, 2023, 14:02 |
Drugs
Vivek Subbiah: The FDA just finalized the draft guidance for 'RARE DISEASE DRUG DEVELOPMENT'
Vivek Subbiah recently shared on LinkedIn: "Wow! The FDA just finalized the draft guidance for…
1
2
All:
14
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube